BOGOR
2012
sativa. Indian J of Med Sci. 25:535-537.
AgroMedia. 2008. 273 Ramuan Tradisional Untuk Mengatasi Aneka Penyakit. Jakarta: AgroMedia Pustaka. hlm 1.
Akoso BT. 2007. Pencegahan dan Pengendalian Rabies. Yogyakarta: Penerbit Kanisius. hlm 121-122.
Anonim. 2009. Jinten Hitam [Terhubung Berkala].
http://perkebunan.litbang.deptan.go.id/. [23 Desember 2009].
Ariens EJ, Mutschler E, Simonis AM. 1985. Toksikologi Umum, Pengantar. Yogyakarta: Gadjah Mada Univ Pr. hlm 143-152.
Astawan M. 2009. Sehat Dengan Hidangan Kacang dan Biji-bijian. Jakarta: Penebar Swadaya. hlm 65.
Babayan VK, Koottungal D, Halaby GA. 1978. Proximate analysis, fatty acid and amino acid composition of Nigella sativa L. seeds.J of Food Sci. 43:1314-1315.
Bagci Y, Arslan D, Ozcan MM, Nesim D. 2007. Determination of mineral contents of bee honeys produced in Middle Anatolia. Int J Food Sci Nut. 58(8): 668-676.
Banks WJ. 1986. Applied Veterinary Histology. Ed ke-2. USA: Williams & Wilkins. hlm 507-510.
Besselsen DG. 2004. Biology of Laboratory Rodent [Terhubung Berkala]. http://www.ahsc.arizona.edu/. [15 Desember 2009].
Chakhravarty N. 1993. Inhibition of histamine release from mast cells by nigellone. Ann Allergy.1993 Mar: 70(3) : 237-42
Constantinescu GM. 2007. Female genital organs. Di dalam: Schatten H, Constantinescu GM, editor. Comparative Reproductive Biology. USA: Blackwell Publishing. hlm 13.
Dellmann HD, Brown EM. 1992. Buku Teks Histologi Veteriner. Ed ke-2. Hartono R, penerjemah. Jakarta: UI Press. Terjemahan dari Textbook of Veterinary Histology. hlm 502-519.
Duryatmo S. 2003. Aneka Ramuan Berkhasiat dari Temu-temuan. Jakarta: Puspa Swara. hlm 8.
El-Dakhakhny M, Barakat M, El-Halim A, Aly SM. 2000. Effect of Nigella sativa oil on gastric secretion and ethanol induced ulcer in rats. J Ethnopharmacol. 2000;72:299–304.
El-Dakhakhny M, Madi NJ, Lembert N, Ammon HP. 2002. Nigella sativa oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipoxygenase products in polymorphonuclear leukocytes from rats. J of Ethnopharmacology. 81:161–164.
El-Kadi A, Kandil O, Tabuni AM. 1989. Nigella sativa and cell mediated immunity. Arch AIDS Res. 1989;1:232-233.
El-Tahir KE, Ashour MMS. 1993. The cardiovascular actions of the volatile oil of the black seed (Nigella Sativa L.) in rats: alucidation of the mechanism of action. Gen Pharmacol. 1993 Sep; 24(5): 1123-31.
Eroschenko, Victor P. 2003. Atlas Histologi di Fiore dengan Korelasi Fungsional. Jakarta: Penerbit Buku Kedokteran EGC. hlm 297-316.
Fatoni. 2011. Bunga jinten hitam [Terhubung Berkala]. http://proherbal.net/herbal-hebat-bernama-habbatussauda/. [26 Juli 2011]. Freeman ME. 1988. The Ovarian Cycle of the Rat. Di dalam: E. Knobil and J.
Neill etal, editor. The PhysiologyofReproduction. New York: Raven Press. hlm 1893-1919.
Gali-Muhtasib A, El-Najjar N, Schneider-Stock R. 2007. The medicinal potential of black seed (Nigella sativa) and its components. Advances in Phytomedicine. 2:133-153.
Ganong WF. 2003. Fisiologi Kedokteran. Jakarta: Buku Kedokteran EGC.
Gerritsma, L.M. 1989. Literature Review: Nigella sativa. Cape Town: Department of Pharmaceutical Chemistry, Potchefstroom University.
Guyton AC, Hall JE. 2007. Buku Ajar Fisiologi Kedokteran. Ed ke-11. Jakarta: EGC. hlm 1064-1075.
Hafez ESE. 2000. Reproduction and Breeding Techniques for Laboratory Animal. Philadelphia: Lea and Febiger. hlm 74-100.
Halfian. 2010. Berbagai tahap perkembangan folikel ovarium [Terhubung Berkala]. http://medicinestuffs.blogspot.com/2010/01/gametogenesis.html. [26 Juli 2011].
activity of nigella sativa against clinical isolates of methicillin resistant staphylococcus aureus. J of Ayub Med College Abbottabad. 20: 72-74. Haq A, Lobo PI, Al-Tufail M, Rama NR, Al-Sedairy ST. 1999.
Immunomodulatory effect of Nigella sativa proteins fractionated by ion exchange chromatography. Int J Immunopharmacol. 21(4): 283-295.
Hardjopranjoto S. 1995. Ilmu Kemajiran Pada Ternak. Surabaya: Airlangga University Pr. hlm 36.
Hoque A, Lippman SM, Wu TT, Xu Y, Liang ZD, Swisher S, Zhang H, Cao L, Ajani JA, Xu XC. 2005. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. J Carcinogenesis. 26:785–791.
Hutapea JR. 1994. Inventaris Tanaman Obat Indonesia. Ed ke-3. Jakarta: Badan Penelitian dan Pengembangan Kesehatan, Depkes RI. hlm 163-165.
Junaedi E, Yuliarti S, Suty S, Kuncari ES. 2011. Kedahsyatan Habbatussauda Mengobati Berbagai Penyakit. Jakarta: AgroMedia Pustaka. hlm 23.
Kesic A, Malazovic M, Crnkic A, Catovic B, Hadzidedic S, Dragisevic G. 2009. The influence of L-ascorbic acid content on total antioxidant activity of bee-honey. Eur J Sci Res 32(1): 96-102.
Khan MA, Ashfaq MK, Zuberi HS, Mahmood MS, Gilani AH. 2003. The in vivo antifungal activity of the aqueous extract from Nigella sativa seeds. J Phytotherapy Res. 17:183–186.
Kolibianakis EM, Papanikolaou EG, Fatemi HM, dan Devroey P. 2005. Estrogen and folliculogenesis: is one necessary for the other?. Curr Opin Obstet Gynecol 17(3): 249-53.
Lestari N. 2009. Uji toksisitas akut ekstrak valerian (Valeriana officinalis) terhadap gastrointestinal mencit [skripsi]. Semarang: Fakultas Kedokteran, Universitas Diponegoro. hlm 25-27.
Malole MBM, Pramono CSU. 1989. Penggunaan Hewan-hewan Percobaan di Laboratorium. Bogor: Departemen Pendidikan dan Kebudayaan, Direktorat Jendral Pendidikan Tinggi dan Kebudayaan, Pusat Antar Universitas Bioteknologi, IPB. hlm 94-103.
Mansour M, Tornhamre S. Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone. 2004. J of Enzyme Inhibition and Med Chem. 19:431–436.
Maslachah L, Sukmanadi M, dan Sugihartuti R. 2004. Pengaruh pemberian antisterilitas Alpha tocopherol terhadap spermatogenesis tikus yang menerima stresor. Jurnal Penelitian Medika Eksakta. 5: 258-269.
Mohammed SEAR, Babiker EE. 2009. Protein structure, physicochemical properties and mineral composition of Apis mellifera honey samples of different floral origin. Australian J Basic and Applied Sci. 3(3): 2477-2483. Montgomery R, Robert LG, Thomas WC, Arthur AS. 1993. Biokimia: Suatu
Pendekatan Berorientasi Kasus. Ismadi, penerjemah. Yogyakarta: Gajah mada University Pr. Terjemahan dari: Biochemistry A Case-Oriented Approach.
Muharam A. 2010. Daun jinten hitam [Terhubung Berkala]. http://bptp-pasirjati.com/2010/09/khasiat-jinten-hitam-temu-irengselama.html. [26 Juli 2011].
Nergiz C, Ötles S. 1993. Chemical composition of Nigella Sativa L. seeds. J Food Chem. 48 : 259-261.
Ownby CL. 2002. Female reproductive system [Terhubung Berkala]. http://www.cvm.okstate./instruction/mm_curr/histology/HistologyReference /HRFemaleRSframe.htm. [23 Januari 2011].
Parhizkar S, Latiff LA, Rahman SA, Dollah MA, Parichehr H. 2011. Assessing estrogenic activity of Nigella sativa in ovariectomized rats using vaginal cornification assay. African J Pharmacy and Pharmacology Vol. 5(2), pp. 137-142.
Pohl P, Sergiel I. 2010. Direct determination of the total concentrations of copper, iron and manganese and their fractionation forms in freshly ripened honeys by means of flame atomic absorption spectrometry. J Microchim Acta (168): 9–15.
Prasetyo Y. 2011. Biopolitik pangan transgenik [Terhubung Berkala]. http://duniayanu.blogspot.com/2011/07/biopolitik-pangan-transgenik.html. [28 Desember 2011].
Qodiriyah T. 2010. Biji jinten hitam [Terhubung Berkala].
http://tarekatqodiriyah.wordpress.com/2010/07/06/pengobatan-cara-rasulullah-saw/. [26 Juli 2011].
Raslytetebano. 2011. Mencit [Terhubung Berkala].
Rosenfeld CS, Schatten H. 2007. Overview of female reproductive organs. Di dalam: Schatten H, Constantinescu GM, editor. Comparative Reproductive Biology. USA: Blackwell Publishing. hlm 105.
Salomi NJ, Nair SC, Jayawardhanan KK, Varghese CD, Panikkar KR. 1992. Antitumour principles from Nigella sativa seeds. J Cancer Lett. 31;63(1):41-6.
Sayyid ABM. 2008. Terapi Herbal Pengobatan Cara Nabi Muhammad SAW. Jakarta: Penebar Plus+. hlm 48-49.
Setiawati A, Zunlida SB, Suyatna FD. 2003. Pengantar farmakologi. Di dalam: Ganiswarna SG, Setiabudy R, Suyatna FD, Purwantyastuti, Nafrialdi, editor. Farmakologi dan Terapi. Jakarta: Bagian Farmakologi Fakultas Kedokteran, Universitas Indonesia. hlm 3-7.
Smith JB, Mangkoewidjojo S. 1988. Pemeliharaan, Pembiakan, dan Penggunaan Hewan Percobaan di Daerah Tropis. Jakarta: UI Pr. hlm 10-20.
Spector WG, Spector TD. 1993. Pengantar Patologi Umum. Ed ke-3. Soetjipto, Harsoyo, Hana A, Astuti P, penerjemah; Moelyono MPE, editor. Yogyakarta: Gadjah Mada Univ Pr. hlm 143. Terjemahan dari: An Introduction to General Pathology.
Suranto A. 2004. Khasiat dan Manfaat Madu Herbal. Tangerang: PT AgroMedia Pustaka.
Toelihere, MR. 1981. Fisiologi Reproduksi Pada Ternak. Bandung: Penerbit Angkasa. hlm 73.
Vegad JL. 1995. Textbook of Veterinary General Pathology. India: Vikas Publishing House PVT LTD. hlm 203-196.
Yatim, W. 1982. Reproduksi dan Embriologi. Bandung: Tarsito. hlm 85.
Yuliarti N. 2008. Racun di Sekitar Kita. Yogyakarta: C.V ANDI OFFSET. hlm 121-122.
Dosis per ekor mencit = 10 mg/kg BB
Dosis untuk mencit (BB = 20 gr) = BB (kg) x Dosis (mg/kg BB) Konsentrasi (mg/ml) = 0,02 x 10
50
= 0,004 ml/ekor.
0,004 ml Albendazole diencerkan dengan menggunakan aquadest sebanyak 0,096 ml, maka dosis pemberian menjadi sebanyak 0,1 ml/ekor.
Perhitungan Dosis Antibiotik
Konsentrasi = 125 mg/5 ml = 25 mg/ml
Dosis untuk anak-anak (BB = 25 kg) = 25 mg/kg BB
Dosis untuk mencit (BB = 20 gr) = BB (kg) x Dosis (mg/kg BB) Konsentrasi (mg/ml) = 0,02 x 25
25
= 0,02 ml/ekor/hari
Sebanyak 0,02 ml AB dengan konsentrasi 25 mg/ml diencerkan dengan menggunakan aquadest sebanyak 0,08 ml, maka dosis pemberian menjadi sebanyak 0,1 ml/ekor.
Perhitungan Dosis Anti Protozoa 1 tablet @ 500 mg/50 kg BB
Dosis pemakaian = 3x500 mg = 30 mg/kg BB 50 kg
Dosis untuk mencit (BB = 20 gr) = BB (kg) x Dosis (mg/kg BB) Konsentrasi (mg/ml) = 0,02 x 30
15
= 0,04 ml/ekor/hari
0,04 ml Anti Protozoa diencerkan dengan menggunakan aquadest sebanyak 0,06 ml, maka dosis pemberian menjadi sebanyak 0,1 ml/ekor.
Perhitungan Dosis Habbatussauda
Dosis Preventif
Manusia BB 50 kg 15 ml/hari = 0,3 ml/kgBB/hari x 2 sendok makan (sdm)
Mencit BB 30 gr 30 gr x 0,6 ml x 3 kali/hari = 0,054 = 0,1 ml/hari 1000gr
Dosis Kuratif
Asumsinya untuk pengobatan yaitu 2 kali dari dosis preventif, maka yang diberikan yaitu 0,2 ml.
Perhitungan Dosis Kombinasi Habbatussauda dengan Madu
Madu untuk manusia dengan BB 50 kg 3 sdm/hari 1 sdm = 15 ml, 1 hari = 45 ml = dosis preventif.
Kombinasi habbatussauda dengan madu diberikan sebanyak 0,3 ml karena perbandingan antara madu : habbatussauda = 20:1.
Duncan PERLAKUAN
N
Subset for alpha = .05 1 HS Kuratif 3 1.4033 HS Preventif 3 1.4700 Kontrol Negatif 2 1.7000 HS Madu 3 2.0900 Sig. .406
Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size = 2.667.
b The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not guaranteed.
Case Processing Summary
Cases
Included Excluded Total
N Percent N Percent N Percent
LUAS OVARIUM * PERLAKUAN 11 91.7% 1 8.3% 12 100.0% Report PERLAKUAN LUAS OVARIUM Kontrol Negatif Mean 1.7000 N 2 Std. Deviation .18385 HS Preventif Mean 1.4700 N 3 Std. Deviation 1.27330 HS Kuratif Mean 1.4033 N 3 Std. Deviation .38423 HS Madu Mean 2.0900 N 3 Std. Deviation .87178 Total Mean 1.6627 N 11 Std. Deviation .77171
Post Hoc Tests Homogeneous Subsets CL Duncan PERLAKUAN N
Subset for alpha = .05 1 Kontrol negatif 2 3.4100 HS Madu 3 3.5133 HS Kuratif 3 4.4833 HS Preventif 3 5.1800 Sig. .462
Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size = 2.667.
b The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not guaranteed.
Case Processing Summary
Cases
Included Excluded Total
N Percent N Percent N Percent
CL * PERLAKUAN 11 100.0% 0 .0% 11 100.0% Report CL PERLAKUAN Mean N Std. Deviation Kontrol negatif 3.4100 2 3.28098 HS Preventif 5.1800 3 2.73896 HS Kuratif 4.4833 3 2.43083 HS Madu 3.5133 3 1.74477 Total 4.2136 11 2.22391
Duncan PERLAKUAN
N
Subset for alpha = .05 1 HS Kuratif 12 17411.2317 HS Preventif 12 17879.3417 Kontrol negatif 8 22386.5625 HS Madu 12 27935.8008 Sig. .112
Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size = 10.667.
b The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not guaranteed.
Case Processing Summary
Cases
Included Excluded Total
N Percent N Percent N Percent
LUAS FOLIKEL TERSIER *
PERLAKUAN 44 57.9% 32 42.1% 76 100.0%
Report
LUAS FOLIKEL TERSIER
PERLAKUAN Mean N Std. Deviation Kontrol negatif 22386.5625 8 15516.69910 HS Preventif 17879.3417 12 11480.60927 HS Kuratif 17411.2317 12 8805.27349 HS Madu 27935.8008 12 17845.31285 Total 21313.8407 44 13935.74633
Post Hoc Tests
Homogeneous Subsets
REGENERASI
Duncan
PERLAKUAN N
Subset for alpha = .05
1 2 Kontrol negatif 10 30.5130 HS Preventif 15 41.2082 41.2082 HS Kuratif 15 42.2238 42.2238 HS Madu 15 57.0853 Sig. .302 .162
Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size = 11.958.
b The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not guaranteed.
Case Processing Summary
Cases
Included Excluded Total
N Percent N Percent N Percent
REGENERASI * PERLAKUAN 55 100.0% 0 .0% 55 100.0% Report REGENERASI PERLAKUAN Mean N Std. Deviation Kontrol negatif 30.5130 10 18.38451 HS Preventif 41.2082 15 35.56550 HS Kuratif 42.2238 15 26.84201 HS Madu 57.0853 15 19.99058 Total 44.1553 55 26.78796
Duncan PERLAKUAN
N
Subset for alpha = .05 1 Kontrol Negatif 10 9.4000 HS Preventif 15 11.6227 HS Kuratif 15 12.7500 HS Madu 15 13.1333 Sig. .106
Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size = 13.333.
b The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not guaranteed.
Case Processing Summary
Cases
Included Excluded Total
N Percent N Percent N Percent
KELENJAR UTERUS * PERLAKUAN 55 100.0% 0 .0% 55 100.0% Report PERLAKUAN KELENJAR UTERUS Kontrol Negatif Mean 9.4000 N 10 Std. Deviation 5.15139 HS Preventif Mean 11.6227 N 15 Std. Deviation 6.46158 HS Kuratif Mean 12.7500 N 15 Std. Deviation 4.18381 HS Madu Mean 13.1333 N 15 Std. Deviation 7.09997 Total Mean 10.5818 N 55 Std. Deviation 6.82232
Post Hoc Tests Homogeneous Subsets SEL GOBLET Duncan PERLAKUAN N
Subset for alpha = .05 1 Kontrol negatif 60 .0000 HS Preventif 90 .0000 HS Kuratif 90 .0000 HS Madu 90 .0222 Sig. .099
Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size = 80.000.
b The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not guaranteed.
Case Processing Summary
Cases
Included Excluded Total
N Percent N Percent N Percent
SEL GOBLET * PERLAKUAN 330 80.5% 80 19.5% 410 100.0% Report SEL GOBLET PERLAKUAN Mean N Std. Deviation Kontrol negatif .0000 60 .00000 HS Preventif .0000 90 .00000 HS Kuratif .0000 90 .00000 HS Madu .0222 90 .14823 Total .0061 330 .07773
PERLAKUAN
N
Subset for alpha = .05 1 HS Madu 30 .4107 Kontrol negatif 20 .3830 HS Preventif 30 .8605 HS Kuratif 30 .6867 Sig. .083
Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size = 26.667.
b The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not guaranteed.
FOLIKEL SEKUNDER
Duncan
PERLAKUAN N
Subset for alpha = .05
1 2 HS Madu 30 .4333 Kontrol negatif 20 .4320 HS Kuratif 30 .5637 .5637 HS Preventif 30 .9523 Sig. .160 .70
Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size = 26.667.
b The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not guaranteed.
FOLIKEL TERSIER Duncan PERLAKUAN N
Subset for alpha = .05 1 Kontrol negatif 20 .2610 HS Madu 30 .2773 HS Kuratif 30 .3100 HS Preventif 30 .4190 Sig. .149
Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size = 26.667.
b The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not guaranteed.
Case Processing Summary
Cases
Included Excluded Total
N Percent N Percent N Percent
PRIMER * PERLAKUAN 110 100.0% 0 .0% 110 100.0% SEKUNDER * PERLAKUA 110 100.0% 0 .0% 110 100.0% TERSIER * PERLAKUA 110 100.0% 0 .0% 110 100.0% Report
PERLAKUAN PRIMER SEKUNDER TERSIER
Kontrol negatif Mean .3830 .4320 .2610 N 20 20 20 Std. Deviation .32366 .34958 .22492 HS Preventif Mean .8605 .9523 .4190 N 30 30 30 Std. Deviation .63251 .74208 .12354 HS Kuratif Mean .6867 .5637 .3100 N 30 30 30 Std. Deviation .39579 .41432 .26417 HS Madu Mean .4107 .4333 .2773 N 30 30 30 Std. Deviation .37348 .31578 .22442 Total Mean .5466 .4425 .3219 N 110 110 110 Std. Deviation .53246 .43677 .36145